Cite
HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancer.
MLA
Xia, Daniel, et al. “HER2/ERBB2 Copy Number Analysis by Targeted next-Generation Sequencing in Breast Cancer.” American Journal of Clinical Pathology, vol. 161, no. 5, May 2024, pp. 436–42. EBSCOhost, https://doi.org/10.1093/ajcp/aqad167.
APA
Xia, D., Kuo, F., Hughes, M., Lindeman, N., Manning, D., Files, J., Strauss, S., Kirkner, G., Mohammed-Abreu, A., Winer, E., Tolaney, S. M., Lin, N. U., & Dillon, D. A. (2024). HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancer. American Journal of Clinical Pathology, 161(5), 436–442. https://doi.org/10.1093/ajcp/aqad167
Chicago
Xia, Daniel, Frank Kuo, Melissa Hughes, Neal Lindeman, Danielle Manning, Janet Files, Sarah Strauss, et al. 2024. “HER2/ERBB2 Copy Number Analysis by Targeted next-Generation Sequencing in Breast Cancer.” American Journal of Clinical Pathology 161 (5): 436–42. doi:10.1093/ajcp/aqad167.